1 active not recruiting, 1 completed, 1 recruiting, 1 terminated. 4 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Active not recruiting 1, Completed 1, Recruiting 1, Terminated 1 |
| Phase 2 | 3 | Active not recruiting 1, Recruiting 1, Terminated 1 |
Follow Celcuity Inc: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
Breast Neoplasms (2) · Genital Diseases, Male (1) · Hereditary Sensory and Autonomic Neuropathies (1) · Male Urogenital Diseases (1) · Prostatic Diseases (1) · Prostatic Neoplasms (1) · Prostatic Neoplasms, Castration-Resistant (1) · Triple Negative Breast Neoplasms (1)
gedatolisib (3) · Fulvestrant (1) · Letrozole (1) · capmatinib (1) · darolutamide (1) · neratinib (1) · palbociclib (1) · talazoparib (1)
United States (4) · France (1) · Spain (1) · United Kingdom (1)
Igor Gorbatchevsky, MD (1) · Kari Wisinski, MD (1) · Nadene Zack, MS (1) · Rachel Layman (1)